ArticleNature communications2025

Autologous HIV-specific T cell therapy targeting conserved epitopes is well-tolerated in six adults with HIV: an open-label, single-arm phase 1 study.

Danielle K Sohai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.